Early Experience With Interleukin-6 Receptor Antagonists in Patients With COVID-19 Admitted to a Community Hospital.

Manning, Kyle; Whitman, Chris; Hohmann, Lindsey; Tubbs, Jessica; Childress, Darrell; Leon de la Rocha, Jose A

Manning, Kyle; Whitman, Chris; Hohmann, Lindsey; Tubbs, Jessica; Childress, Darrell; Leon de la Rocha, Jose A.

Afiliación

Manning K; University of Utah Health, Salt Lake City, UT, USA.
Whitman C; Infirmary Health, Mobile, AL, USA.
Hohmann L; Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
Tubbs J; East Alabama Rheumatology Center, East Alabama Medical Center, Opelika, AL, USA.
Childress D; East Alabama Medical Center, Opelika, AL, USA.
Leon de la Rocha JA; Edward Via College of Osteopathic Medicine, Auburn, AL, USA.

J Pharm Technol ; 38(5): 255-263, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36046347

Palabras clave

COVID-19; coronavirus disease 2019; cytokine storm; interleukin-6 inhibitors; tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Technol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google